MX2009002985A - Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh). - Google Patents

Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh).

Info

Publication number
MX2009002985A
MX2009002985A MX2009002985A MX2009002985A MX2009002985A MX 2009002985 A MX2009002985 A MX 2009002985A MX 2009002985 A MX2009002985 A MX 2009002985A MX 2009002985 A MX2009002985 A MX 2009002985A MX 2009002985 A MX2009002985 A MX 2009002985A
Authority
MX
Mexico
Prior art keywords
tsh
formulations
stimulating hormone
thyroid stimulating
therapeutic administration
Prior art date
Application number
MX2009002985A
Other languages
English (en)
Spanish (es)
Inventor
Eliana Clark
James Magner
Jeffrey Skell
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2009002985A publication Critical patent/MX2009002985A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2009002985A 2006-09-19 2007-09-18 Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh). MX2009002985A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84607706P 2006-09-19 2006-09-19
PCT/US2007/020221 WO2008036271A1 (en) 2006-09-19 2007-09-18 Formulations for therapeutic administration of thyroid stimulating hormone (tsh)

Publications (1)

Publication Number Publication Date
MX2009002985A true MX2009002985A (es) 2009-04-01

Family

ID=39018092

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002985A MX2009002985A (es) 2006-09-19 2007-09-18 Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh).

Country Status (13)

Country Link
US (1) US20100048455A1 (enExample)
EP (1) EP2063909B1 (enExample)
JP (1) JP2010503689A (enExample)
AR (1) AR062894A1 (enExample)
BR (1) BRPI0717077A2 (enExample)
CA (1) CA2663323A1 (enExample)
DK (1) DK2063909T3 (enExample)
ES (1) ES2396502T3 (enExample)
MX (1) MX2009002985A (enExample)
PL (1) PL2063909T3 (enExample)
PT (1) PT2063909E (enExample)
SI (1) SI2063909T1 (enExample)
WO (1) WO2008036271A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2793948B1 (en) * 2011-12-19 2022-03-23 Genzyme Corporation Thyroid stimulating hormone compositions
ES2947985T3 (es) * 2017-12-14 2023-08-25 The London Psychiatry Centre Tratamiento de la depresión resistente mediante la aplicación de estimulación magnética transcraneal repetitiva con tratamiento con hormona tiroidea
CN113740523A (zh) * 2021-09-14 2021-12-03 首都医科大学附属北京朝阳医院 一种基于量值溯源的tsh多系统赋值方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0228604A3 (en) * 1985-12-11 1988-10-12 Sloan-Kettering Institute For Cancer Research Isolation of a gene encoding human thyrotropin beta subunit
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
KR100642599B1 (ko) * 1997-09-22 2006-11-10 유니버시티 어브 메릴랜드, 발티모어 갑상선 자극 호르몬의 변이체 및 이에 근거한 방법
CN1321092A (zh) * 1998-06-30 2001-11-07 安姆根有限公司 用于生物活性剂的延缓给药的热敏生物可降解水凝胶
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
US20080167223A1 (en) * 2004-04-16 2008-07-10 Mount Sinai School Of Medicine Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity

Also Published As

Publication number Publication date
ES2396502T3 (es) 2013-02-22
JP2010503689A (ja) 2010-02-04
SI2063909T1 (sl) 2013-02-28
EP2063909B1 (en) 2012-10-24
US20100048455A1 (en) 2010-02-25
DK2063909T3 (da) 2013-01-02
BRPI0717077A2 (pt) 2013-11-26
AR062894A1 (es) 2008-12-10
PT2063909E (pt) 2013-01-15
EP2063909A1 (en) 2009-06-03
WO2008036271A1 (en) 2008-03-27
PL2063909T3 (pl) 2013-05-31
CA2663323A1 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
MX2010009851A (es) Oblea gingival.
UA104869C2 (uk) Фармацевтичні композиції, що містять ліганди рецептора дофаміну
MY153976A (en) Lh liquid formulations
MX2010010647A (es) Proceso para preparar formulaciones de dabigatran para administracion oral.
NZ593110A (en) pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS
CY1108690T1 (el) Υποκατεστημενες ν-αρυλοπυρρολιδινες ως επιλεκτικοι διαμορφωτες υποδοχεα ανδρογονων
IL197393A (en) History of pyridine-4-ram, containing and using pharmaceutical preparations for the preparation of drugs for the treatment of immune-related diseases
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
NZ605873A (en) Methods and compositions for cns delivery of arylsulfatase a
WO2005112633A3 (en) Compounds and compositions for delivering active agents
MX355885B (es) Composición farmacéutica de administración oral.
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
MY165041A (en) Composition for improving brain function and method for improving brain function
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
MX2009002985A (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh).
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
MY179041A (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
PH12013500027A1 (en) Therapeutic agents 976
WO2009043577A3 (de) 19-nor-progesterone zur kontrazeption
AU2005238141A8 (en) Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
TW200531693A (en) Prolonged-release diuretic compositions
MX2008002272A (es) Compuestos de ciclopropilo y composiciones para suministrar agentes activos.

Legal Events

Date Code Title Description
FG Grant or registration